Stoke, Iovance, and Context Therapeutics granted stock options to new hires under Nasdaq’s inducement rule to attract biotech talent.

Stoke Therapeutics, Iovance Biotherapeutics, and Context Therapeutics each announced stock option grants to new employees under Nasdaq’s inducement award rule, which allows companies to grant equity without shareholder approval when hiring key personnel. The moves are part of broader efforts to attract talent in the biotechnology sector. Specific details on the number of shares or strike prices were not provided in the announcements.